Healthcare AI investors writing $5M-$25M checks

Investors whose typical check size falls in the $5M-$25M range for healthcare AI deals. Useful for sizing your round and identifying the right tier of partners.

Checks of this magnitude define the core of Series B and Series C growth equity. Massive capital is injected into highly derisked, rapidly revenue-generating healthcare companies to fund international expansion, strategic acquisitions, and to achieve complete market domination.
294 investors match

Within $5M-$25M: top investment stages

Series B (225) Series A (198) Growth (181) Series C (117) Seed (82) Series D+ (19) Pre-Seed (16)
Samsara BioCapital
VC T3
Palo Alto, United States
$5M-$25M
Samsara BioCapital is a Palo Alto-based venture firm that invests in life sciences companies, with a focus on biotech and pharma and…
Biotech Pharma / Therapeutics
Sanofi Ventures
Corporate VC AI T1
Cambridge, United States
$5M-$25M
Sanofi Ventures is the strategic investing arm of one of the world’s largest pharmaceutical companies, and it operates with the patience and…
AI/ML in Healthcare Biotech
Scale Venture Partners
VC T3
Foster City, United States
$5M-$25M
Scale Venture Partners is a Foster City-based growth-stage software firm investing primarily in B2B SaaS, with a long track record of leading…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
Schooner Capital
VC T3
Boston, United States
$5M-$25M
Schooner Capital is a privately held growth equity investor based in Boston, with healthcare positions across care delivery, tech-enabled services, and life…
Care Delivery / Tech-Enabled Services Life Sciences Tools
Seroba Life Sciences
VC T3
Dublin, Ireland
$5M-$25M
Seroba Life Sciences is a pan-European life sciences venture firm headquartered in Dublin that backs biotech and medtech innovators across the United…
Biotech Medical Devices / MedTech
Shanghai Biomedical Fund
PE T3
Shanghai, China
$5M-$25M
Shanghai Biomedical Fund is a state-backed equity vehicle structured to drive the industrialization of Shanghai’s biomedicine sector, including biotech and pharma therapeutics…
Biotech Pharma / Therapeutics
Shanghai Pharma
Corporate VC T3
Shanghai, China
$5M-$25M
Shanghai Pharma is a massive Chinese pharmaceutical manufacturer that utilizes strategic venture investments through its corporate venture arm to acquire innovative pipelines…
Biotech Diagnostics
Shenzhen Capital Group
VC AI T3
Shenzhen, China
$5M-$25M
Shenzhen Capital Group is one of the largest government-originated venture organizations in China, with a multi-decade history of channeling capital into hard…
AI/ML in Healthcare Biotech
Sheridan Capital Partners
PE T3
Chicago, United States
$5M-$25M
Sheridan Capital Partners is a Chicago healthcare-focused private equity firm partnering with founders to build consumer-centric clinical service platforms. Healthcare sub-vertical focus…
Care Delivery / Tech-Enabled Services
Sherpa Healthcare Partners
VC AI T3
Beijing, China
$5M-$25M
Sherpa Healthcare Partners is a Beijing-headquartered venture firm dedicated exclusively to healthcare, with a focus on life technologies and innovative therapeutics. The…
Biotech Diagnostics
Siam Commercial Bank Ventures
Corporate VC AI T2
Bangkok, Thailand
$5M-$25M
Siam Commercial Bank Ventures, branded SCB 10X, is the technology and venture investment unit of Thailand’s Siam Commercial Bank, writing Series A,…
AI/ML in Healthcare Digital Health
Siana Capital
VC AI T2
Bengaluru, India
$5M-$25M
Siana Capital is a Bengaluru-based mid-market technology-focused VC writing $5M to $25M checks at Series B and Series C into AI and…
AI/ML in Healthcare Health IT / Healthcare Software
Signet Healthcare Partners
PE T3
New York, United States
$5M-$25M
Signet Healthcare Partners is a New York-based growth equity firm focused exclusively on commercial-stage healthcare companies, with a portfolio that spans pharmaceutical…
Care Delivery / Tech-Enabled Services Diagnostics
Sinopharm Capital
Corporate VC T3
Shanghai, China
$5M-$25M
Sinopharm Capital is the equity investment platform of Sinopharm, the state-owned Chinese pharmaceutical group, and operates from Shanghai with a strategic rather…
Diagnostics Medical Devices / MedTech
SK Investment
Corporate VC T3
Seoul, South Korea
$5M-$25M
SK Investment is the corporate vehicle of South Korea’s SK Group, driving global investments to upgrade existing business models via strategic pharmaceutical…
Biotech Life Sciences Tools
AI Tool Finder
AI-powered search. Results may not be comprehensive.